Evaluation of Additional Treatments for COVID-19: a Randomized Trial in Niger
Status:
Withdrawn
Trial end date:
2020-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess whether lopinavir/ritonavir (or eventually other
antiviral drugs) is effective at reducing the rate of hospitalization among confirmed
COVID-19 cases treated as outpatients.